Indeed, Axin1 mutations—the other common WNT pathway alteration in HCC—also do not robustly activate WNT signalling but upregulate a subset of WNT-target genes permissive to tumorigenesis35. This evidence concerns the gene AXIN1 and hepatocellular carcinoma.